{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:51:23Z","timestamp":1787161883273,"version":"build-2736575974"},"reference-count":59,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.3201\/eid0706.010602","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T15:10:11Z","timestamp":1253286611000},"page":"920-926","source":"Crossref","is-referenced-by-count":110,"title":["Developing New Smallpox Vaccines"],"prefix":"10.3201","volume":"7","author":[{"given":"Steven R.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Merchlinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Kleppinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Goldenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid0706.010602-202410200958-R1","unstructured":"Testimony of Stephen M. Ostroff. Mar 8, 2000; U.S. House of Representatives Committee on Commerce. National Security, Veterans Affairs, and International Relations. Available at: URL: www.bt.cdc.gov\/press\/ostroff_03082000.asp"},{"key":"key-10.3201\/eid0706.010602-202410200958-R2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism.","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"key":"key-10.3201\/eid0706.010602-202410200958-R3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3201\/eid0504.990415","article-title":"Smallpox: clinical and epidemiologic features.","volume":"5","author":"Henderson","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid0706.010602-202410200958-R4","unstructured":"Broad WJ, Miller J. Government report says 3 nations hide stocks of smallpox. New York Times; Jun 13, 1999. Available at URL: http:\/\/nytimes.qpass.com\/qpass-archives\/"},{"key":"key-10.3201\/eid0706.010602-202410200958-R5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199808203390811","article-title":"Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism.","volume":"339","author":"Bremen","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R6","doi-asserted-by":"publisher","DOI":"10.3201\/eid0706.010607","article-title":"Modeling potential responses to smallpox as a bioterrorist weapon.","volume":"7","author":"Meltzer","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid0706.010602-202410200958-R7","unstructured":"Preston R. The demon in the freezer. The New Yorker 1999; July 12:44-61."},{"key":"key-10.3201\/eid0706.010602-202410200958-R8","first-page":"387","article-title":"Smallpox vaccine no longer available for civilians--United States.","volume":"32","author":"Centers for Disease Control","year":"1983","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1086\/513968","article-title":"Immunologic responses to vaccinia vaccines administered by different parenteral routes.","volume":"175","author":"McClain","year":"1997","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid0706.010602-202410200958-R10","first-page":"63","article-title":"Laboratory and vaccination studies with dried smallpox vaccines.","volume":"16","author":"Cockburn","year":"1957","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid0706.010602-202410200958-R11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/apm.1965.63.1.97","article-title":"Smallpox vaccination studies with serial dilutions of vaccine.","volume":"63","author":"Espmark","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"key-10.3201\/eid0706.010602-202410200958-R12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4269\/ajtmh.1975.24.656","article-title":"Smallpox vaccination revisited: some observations on the biology of vaccinia.","volume":"24","author":"Koplan","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid0706.010602-202410200958-R13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/vim.1990.3.19","article-title":"Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA.","volume":"3","author":"Lublin-Tennenbaum","year":"1990","journal-title":"Viral Immunol"},{"key":"key-10.3201\/eid0706.010602-202410200958-R14","first-page":"492","article-title":"Complications of vaccination against smallpox.","volume":"76","author":"Greenberg","year":"1948","journal-title":"Am J Dis Child"},{"key":"key-10.3201\/eid0706.010602-202410200958-R15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1542\/peds.39.6.916","article-title":"Complications of smallpox vaccination--United States, 1963. II. Results obtained by four statewide surveys.","volume":"39","author":"Neff","year":"1967","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid0706.010602-202410200958-R16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM196701192760301","article-title":"Complications of smallpox vaccination. I. National survey in the United States, 1963.","volume":"276","author":"Neff","year":"1967","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1542\/peds.50.3.481","article-title":"Complications of smallpox vaccination: 1968 surveillance in a comprehensive care clinic.","volume":"50","author":"Neff","year":"1972","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid0706.010602-202410200958-R18","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJM196911272812205","article-title":"Routine childhood vaccination against smallpox reconsidered.","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of smallpox vaccination, 1968. National surveillance in the United States.","volume":"281","author":"Lane","year":"1969","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/122.4.303","article-title":"Complications of smallpox vaccination, 1968: results of ten statewide surveys.","volume":"122","author":"Lane","year":"1970","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid0706.010602-202410200958-R21","first-page":"129","article-title":"Progressive vaccinia in immunologically deficient individuals. New York: The National Foundation-March of Dimes, Birth Defects, Original Article Series","volume":"4","author":"Fulginiti","year":"1968","journal-title":"Immunologic Deficiency Diseases in Man"},{"key":"key-10.3201\/eid0706.010602-202410200958-R22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/bmj.2.5414.906","article-title":"Eczema vaccinatum.","volume":"2","author":"Copeman","year":"1964","journal-title":"BMJ"},{"key":"key-10.3201\/eid0706.010602-202410200958-R23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1056\/NEJM195806192582507","article-title":"Acute pericarditis after smallpox vaccination.","volume":"258","author":"Cangemi","year":"1958","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJM196901092800223","article-title":"Postvaccination arthritis.","volume":"280","author":"Holtzman","year":"1969","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/archderm.97.4.400","article-title":"Malignant tumors in smallpox vaccination scars.","volume":"97","author":"Marmelzat","year":"1968","journal-title":"Arch Dermatol"},{"key":"key-10.3201\/eid0706.010602-202410200958-R26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jama.212.3.441","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968.","volume":"212","author":"Lane","year":"1970","journal-title":"JAMA"},{"key":"key-10.3201\/eid0706.010602-202410200958-R27","first-page":"37","article-title":"Contact spread of vaccinia from a recently vaccinated Marine--Louisiana.","volume":"33","author":"Centers for Disease Control","year":"1984","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R28","first-page":"182","article-title":"Contact spread of vaccinia from a National Guard vaccinee--Wisconsin.","volume":"34","author":"Centers for Disease Control","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R29","first-page":"453","article-title":"Vaccinia outbreak--Newfoundland.","volume":"30","author":"Centers for Disease Control","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R30","first-page":"403","article-title":"Vaccinia outbreak--Nevada.","volume":"32","author":"Centers for Disease Control","year":"1983","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease.","volume":"316","author":"Redfield","year":"1987","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0706.010602-202410200958-R32","unstructured":"WHO Expert Group on Requirements for Biological Substances. Manufacturing establishments and control laboratories-Poliomyelitis vaccine(inactivated)-Poliomyelitis vaccine (oral)-Smallpox vaccine. WHO Tech. Report Series No. 323. Geneva: The Organization; 1965."},{"key":"key-10.3201\/eid0706.010602-202410200958-R33","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: World Health Organization; 1988."},{"key":"key-10.3201\/eid0706.010602-202410200958-R34","unstructured":"U.S. Food and Drug Administration, Center for Biologics Evaluation and Research. Points to consider in the characterization of cell lines used to produce biologicals, 5\/17\/1993. Available at: URL: http:\/\/www.fda.gov\/cber\/guidelines.htm#ichE11"},{"key":"key-10.3201\/eid0706.010602-202410200958-R35","first-page":"19","article-title":"Inc. Vero cell standardized tests for adventitious agents urged by FDA panel.","volume":"62","author":"Reports","year":"2000","journal-title":"Pink Sheet"},{"key":"key-10.3201\/eid0706.010602-202410200958-R36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0264-410X(94)90215-1","article-title":"Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines.","volume":"12","author":"Sugimoto","year":"1994","journal-title":"Vaccine"},{"key":"key-10.3201\/eid0706.010602-202410200958-R37","unstructured":"Hirayama M. Smallpox vaccination in Japan. In: The vaccination: theory and practice. Tokyo: International Medical Foundation of Japan; 1975. p. 113-24."},{"key":"key-10.3201\/eid0706.010602-202410200958-R38","first-page":"195","article-title":"Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus.","volume":"84","author":"Sutter","year":"1995","journal-title":"Dev Biol Stand"},{"key":"key-10.3201\/eid0706.010602-202410200958-R39","unstructured":"Schofield T. Assay development. Assay validation. In: Chow S-C, editor. Encyclopedia of biopharmaceutical statistics. New York: Marcel Dekker, Inc.; 2000. p. 13-20."},{"key":"key-10.3201\/eid0706.010602-202410200958-R40","unstructured":"Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; final rule. Federal Register Vol. 63. 1998;63:66631-72."},{"key":"key-10.3201\/eid0706.010602-202410200958-R41","unstructured":"Food and Drug Administration. Draft guidance for industry: recommendations for complying with the pediatric rule. 21 CFR 314.55(a) and 601.27(a). (2000)."},{"key":"key-10.3201\/eid0706.010602-202410200958-R42","first-page":"64607","article-title":"Postmarketing studies for approved human drug and licensed biological products; status reports.","volume":"65","author":"Food and Drug Administration","year":"2000","journal-title":"Fed Regist"},{"key":"key-10.3201\/eid0706.010602-202410200958-R43","first-page":"1","article-title":"Recommendations of the Immunization Practices Advisory Committee (ACIP): vaccinia (smallpox) vaccine.","volume":"40","author":"Centers for Disease Control","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R44","first-page":"41","article-title":"The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox.","volume":"25","author":"Kempe","year":"1961","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid0706.010602-202410200958-R45","first-page":"317","article-title":"Prophylactic effect on antivaccinia gamma-globulin against post-vaccinal encephalitis.","volume":"27","author":"Nanning","year":"1962","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid0706.010602-202410200958-R46","first-page":"126","article-title":"Illness attributed to smallpox vaccination during 1951-60.","volume":"23","author":"Conybeare","year":"1964","journal-title":"Mon Bull Minist Health Public Health Lab Serv"},{"key":"key-10.3201\/eid0706.010602-202410200958-R47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","article-title":"Hyperimmune vaccinal gamma globulin.","volume":"18","author":"Kempe","year":"1956","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid0706.010602-202410200958-R48","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S0022-3476(65)80221-9","article-title":"Complications of smallpox vaccination. Effects of vaccinia immune globulin therapy.","volume":"67","author":"Sussman","year":"1965","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid0706.010602-202410200958-R49","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0140-6736(73)92215-0","article-title":"Experience of anti-vaccinia immunoglobulin in the United Kingdom.","volume":"1","author":"Sharp","year":"1973","journal-title":"Lancet"},{"key":"key-10.3201\/eid0706.010602-202410200958-R50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1542\/peds.55.3.342","article-title":"Smallpox vaccination reactions, prophylaxis, and therapy of complications.","volume":"55","author":"Goldstein","year":"1975","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid0706.010602-202410200958-R51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1423-0410.1976.tb02224.x","article-title":"The efficacy of vaccinial immune globulin. A 15-year study.","volume":"31","author":"Feery","year":"1976","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid0706.010602-202410200958-R52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archopht.1965.00970040541019","article-title":"Therapy of experimental vaccinal keratitis. Effect of idoxuridine and VIG.","volume":"74","author":"Fulginiti","year":"1965","journal-title":"Arch Ophthamol"},{"key":"key-10.3201\/eid0706.010602-202410200958-R53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(66)90006-7","article-title":"Treatment of eczema vaccinatum with N-methylisatin beta-thiosemicarbazone.","volume":"1","author":"Adels","year":"1966","journal-title":"Lancet"},{"key":"key-10.3201\/eid0706.010602-202410200958-R54","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(65)92840-0","article-title":"Methisazone in prevention of variola minor among contacts.","volume":"2","author":"do Valle","year":"1965","journal-title":"Lancet"},{"key":"key-10.3201\/eid0706.010602-202410200958-R55","first-page":"265","article-title":"Adverse reactions to smallpox vaccination--1978.","volume":"28","author":"Centers for Disease Control","year":"1979","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0706.010602-202410200958-R56","unstructured":"Remarks by the President at the United States Naval Academy commencement. May 22, 1998. Available at: URL: http:\/\/www.cnn.com\/ALLPOLITICS\/1998\/05\/22\/clinton.academy\/transcript.html"},{"key":"key-10.3201\/eid0706.010602-202410200958-R57","first-page":"53960","article-title":"New drug and biological drug products: evidence needed to demonstrate efficacy of new drugs for use against lethal or permanently disabling toxic substances when efficacy studies in humans ethically cannot be conducted.","volume":"64","author":"Food and Drug Administration","year":"1999","journal-title":"Fed Regist"},{"key":"key-10.3201\/eid0706.010602-202410200958-R58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.","volume":"181","author":"Bray","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid0706.010602-202410200958-R59","unstructured":"Institute of Medicine. Assessment of future scientific needs for live variola virus. Washington: National Academy Press; 1999."}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/7\/6\/01-0602_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T21:39:42Z","timestamp":1732570782000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/7\/6\/01-0602_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"URL":"https:\/\/doi.org\/10.3201\/eid0706.010602","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}